ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiologic methods"

  • Abstract Number: 303 • 2013 ACR/ARHP Annual Meeting

    Risk Of Cardiovascular Events In Patients With Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A General Population-Based Cohort Study

    Alexis Ogdie1, Yiding Yu2, Kevin Haynes3, Samantha Maliha4, Thorvardur Love5,6, Andrea Troxel7, Sean Hennessy8, David Margolis9, Stephen Kimmel10, Nehal N. Mehta11, Hyon Choi12,13 and Joel Gelfand14, 1Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 2Medicine, Brigham and Women's Hospital, Boston, MA, 3Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 4University of Pennsylvania, Philadelphia, PA, 5Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 6Landspitali University Hospital, Reykjavik, Iceland, 7Biostatistics and Epidemiology, University of Pennsylvania., Philadelphia, PA, 8Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 9Dermatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 10Cardiology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 11National Heart Lung Blood Institute, Cardiovascular and Pulmonary Division, NHLBI, National Institutes of Health, Bethesda, MD, 12Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 13Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA, 14Dermatology and Epidemiology, University of Pennsylvania., Philadelphia, PA

    Risk of Cardiovascular Events in Patients with Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A general population-based cohort studyBackground/Purpose: Psoriatic arthritis (PsA), psoriasis, and rheumatoid arthritis…
  • Abstract Number: 1271 • 2013 ACR/ARHP Annual Meeting

    Longitudinal Disease Trajectory Of Juvenile Dermatomyositis

    Lily Siok Hoon Lim1,2, Eleanor Pullenayegum3, Dafna D. Gladman4, Earl D. Silverman5 and Brian M. Feldman6, 1Pediatric Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 2Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada, 3Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, 4Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 5Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 6Rheumatology, Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: 1) To determine the longitudinal disease activity trajectory of an inception cohort of Juvenile Dermatomyositis (JDM) patients, 2) To identify predictor(s) for longitudinal disease…
  • Abstract Number: 261 • 2013 ACR/ARHP Annual Meeting

    Concordance Of Hip Pain With Radiographic Hip Osteoarthritis In An Urban US Community: The Framingham Osteoarthritis Study

    Kyu Chan Kim1, David T. Felson2, Katherine D. Linsenmeyer3, Ali Guermazi4, Steven C. Vlad5, Mary M. Clancy6 and Jingbo Niu7, 1Internal Medicine and Rheumatology, Boston Medical Center, Boston, MA, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Internal Medicine, Boston Medical Center, Boston, MA, 4Boston University, Boston, MA, 5Clinical Epidemiology, Boston University, Boston, MA, 6School of Medicine, Boston University, Boston, MA, 7Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: While it is well known that knee pain and radiographic knee osteoarthritis (OA) are often discordant, little is known of the concordance of hip…
  • Abstract Number: 1235 • 2013 ACR/ARHP Annual Meeting

    Predictors Of Fracture In Patients With Osteopenia: Data From An Observational Cohort

    Kathryn Mitchell1, Peter Diggle1 and Marwan Bukhari1,2, 1Faculty of Health and Medicine, Lancaster, United Kingdom, 2Department of Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

    Background/Purpose: The risk factors for osteoporotic fragility fractures are well documented in the literature and although they are associated with a diagnosis of established osteoporosis…
  • Abstract Number: 262 • 2013 ACR/ARHP Annual Meeting

    Is There a Role For Non-Mendelian Inheritance In Severe Osteoarthritis Of The Knee

    Allen D. Sawitzke1, Richard Pimentel2, Jathine Wong2, Helena Martinez3, Marta Herrero3, Josep Verges4 and Daniel O. Clegg5, 1Rheumatology, University of Utah, Salt Lake City, UT, 2University of Utah, Salt Lake, UT, 3Pharmascience Division, Bioiberica S.A., Barcelona, Spain, 4Pharmacological Research Unit, Scientific Medical Department, Bioibérica, S.A., Barcelona, Spain, 5Rheumatology, George Wahlen VA Medical Center/University of Utah, Salt Lake City, UT

    Background/Purpose: Although the etiopathogenesis of osteoarthritis of the knee remains largely unknown, it is clear that genetic risks are contributory. Traditional family, twin, case control…
  • Abstract Number: 137 • 2013 ACR/ARHP Annual Meeting

    A Population-Based Survey and Physician Assessment Of The Characteristics and Prevalence Of Fibromyalgia

    Edgar H. Adams1, Shoshana Daniel2, Arthi B. Chandran3, Heather McElroy4, Caroline Schaefer1, Rachael Mann5, Gergana Zlateva3, Joseph C. Cappelleri6, Elizabeth T. Masters7, Annlouise R. Assaf6, Michael McNett8, Stuart L. Silverman9, Roland Staud10 and Philip Mease11, 1Covance Market Access Services Inc., Gaithersburg, MD, 2Covance Market Access Services Inc., Conshohocken, PA, 3Pfizer Inc., New York, NY, 4Covance Market Access Services, Sydney, Australia, 5Covance Market Access Services Inc., San Diego, CA, 6Pfizer Inc., Groton, CT, 7Pfizer Inc, New York, NY, 8Aurora Pain Program, Milwaukee, WI, 9Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA, 10Dept Med/Rheum/Clin Immun Div, University of Florida, Gainesville, FL, 11Director, Rheumatology Research, Swedish Medical Center, Seattle, WA

    Background/Purpose: No large-scale, national study estimating fibromyalgia (FM) prevalence in the United States (US) has been conducted involving physician evaluation.  The study objective was to…
  • Abstract Number: 1220 • 2013 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Characteristics and Fracture Risk: A Population-Based Study

    Shreyasee Amin1, Sherine E. Gabriel2, Sara J. Achenbach3, Elizabeth J. Atkinson3, Terry M. Therneau3 and L. Joseph Melton III3, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: Women and men with rheumatoid arthritis [RA] are at increased risk for a fragility fracture [fx]. To help better target those in need of…
  • Abstract Number: 243 • 2013 ACR/ARHP Annual Meeting

    The Association Between Metabolic Syndrome and Hand Osteoarthritis – Data From The Framingham Study

    Ida K. Haugen1, Vasan Ramachandran2,3, Devyani Misra4, Tuhina Neogi4, Jingbo Niu4, Yuqing Zhang5 and David T. Felson5, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, MA, 3Cardiology, Boston University School of Medicine, Boston, MA, 4Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 5Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Metabolic factors may have a negative effect on cartilage, and may be especially relevant in the pathogenesis of hand OA. Our aim was to…
  • Abstract Number: 2829 • 2013 ACR/ARHP Annual Meeting

    Statin Adherence and Risk Of Mortality In Patients With Rheumatoid Arthritis: A Population-Based Study

    Mary De Vera1,2, Michal Abrahamowicz3 and Diane Lacaille4, 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, 4Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada

    Background/Purpose: Poor adherence with statin therapy is associated with increased mortality in the general population, but no corresponding data are available among patients with rheumatoid…
  • Abstract Number: 1209 • 2013 ACR/ARHP Annual Meeting

    Starting Time Of Inflammatory Attacks In Patients With Familial Mediterranean Fever

    Feyza Berktas1, Nilufer Alpay Kanitez1, Bahtiyar Toz1, Oguz Kaan Bakkaloglu1, Burak Erer2 and Ahmet Gul1, 1Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Internal Medicine, Rheumatology Division, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

    Background/Purpose: Familial Mediterranean fever (FMF), the most common form of the hereditary autoinflammatory diseases, is characterized by recurrent self-limiting attacks of fever and/or serositis accompanied…
  • Abstract Number: 96 • 2013 ACR/ARHP Annual Meeting

    Epidemiology and Health Services Use For Osteoarthritis By First Nations People In Alberta, Canada

    Cheryl Barnabe1, Allyson Jones2, Ed Enns3, Don Voaklander4, Christine Peschken5, Joanne Homik4, John Esdaile6, Sasha Bernatsky7, Brenda Hemmelgarn8 and Deborah Marshall9, 1Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, 2Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, 3Alberta Bone and Joint Health Institute, Calgary, AB, Canada, 4University of Alberta, Edmonton, AB, Canada, 5Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 6Medicine, University of British Columbia, Vancouver, BC, Canada, 7Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, 8Division of Nephrology, University of Calgary, Calgary, AB, Canada, 9University of Calgary, Calgary, AB, Canada

    Background/Purpose: Self-reported survey data and a single provincial administrative data source have previously indicated that the First Nations (FN) population in Canada has a 1.5…
  • Abstract Number: 2759 • 2013 ACR/ARHP Annual Meeting

    Can RA Registries Provide Contextual Safety Data For Modern RCTs?

    Kaleb Michaud1, Johan Askling2, Hisashi Yamanaka3, Deborah Symmons4, Marie Holmqvist2, Thomas Frisell5, George Reed6, Dimitrios A. Pappas7, Eiichi Tanaka8, Eisuke Inoue9, Suzanne M.M. Verstappen4, Christopher Garwood4, Laura Horne10, Kathy Lampl11, Niklas Berglind12, Stefan Franzen12, Fredrik Nyberg13, Trung Tran14, Meilien Ho15 and Jeffrey D. Greenberg16, 1Rheumatology, National Data Bank for Rheumatic Diseases & University of Nebraska Medical Center, Omaha, NE, 2Karolinska Institutet, Stockholm, Sweden, 3Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 4Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 5Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 6Orthopedics, University of Massachusetts Medical School, Worcester, MA, 7Columbia University, New York, NY, 8Tokyo Women's Medical University, Tokyo, Japan, 9Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 10AstraZeneca, Wilmington, DE, 11AstraZeneca R&D Wilmington, Wilmington, DE, 12AstraZeneca R&D Mölndal, Mölndal, Sweden, 13AstraZeneca R&D, Mölndal, Sweden, 14MedImmune LLC, Gaithersburg, MD, 15AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, 16New York University School of Medicine, New York, NY

    Background/Purpose: For ethical reasons, modern phase-III RCTs in rheumatoid arthritis (RA) have limited placebo exposure time, resulting in uncertainties when interpreting low frequency adverse events…
  • Abstract Number: 1052 • 2013 ACR/ARHP Annual Meeting

    Glucocorticosteroids and Mortality Risk In Rheumatoid Arthritis – Results Of a Population Based Study

    Diane Lacaille1, J. Antonio Avina-Zubieta2,3, Eric C. Sayre2, Michal Abrahamowicz4 and John Esdaile1,5, 1Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, 2Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, 5Medicine, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Glucocorticosteroids (GC) are frequently used in the management of rheumatoid arthritis (RA). Due to their metabolic and immunosuppressive effects, they could increase the risk…
  • Abstract Number: 2682 • 2013 ACR/ARHP Annual Meeting

    Incidence Trends and Predictors Of Orthopedic Surgery In Patients With Rheumatoid Arthritis – Results From a Well Defined Population

    Korosh Hekmat1, Lennart Jacobsson2, Jan-Åke Nilsson3, Minna Willim4, Martin Englund5, Ingemar F. Petersson6 and Carl Turesson2, 1Department of Clinical Sciences, Section of Rheumatology, Malmö, Lund University, Malmö, Sweden, 2Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 4Department of Clinical Sciences Malmö, Section of Rheumatology, Lund University, Malmö, Sweden, 5Department of Orthopedics, Clinical Sciences Lund,, Lund University, Lund, Sweden, 6Musculoskeletal Scienes, Department of Orthopedics, Clinical Sciences, Lund, Sweden

    Background/Purpose:  Orthopedic surgery is used effectively in many patients with severe rheumatoid arthritis (RA). The aim of modern pharmacologic treatment is to prevent joint destruction…
  • Abstract Number: 1067 • 2013 ACR/ARHP Annual Meeting

    Incidence and Prevalence Of Systemic Lupus Erythematosus: A 2010 Nation-Wide Population-Based Study Using French National Administrative Databases

    Laurent Arnaud1, Jean-Paul Fagot2, Michel Païta2, Alexis Mathian3, Anne Fagot-Campagna2 and Zahir Amoura4, 1Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, 2Caisse Nationale d’Assurance Maladie des Travailleurs Salariés, Paris, France, 3Internal Medicine Dpt 2, Pitié-Salpêtrière Hospital, APHP, Paris, France, 4Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France

    Background/Purpose: To date, only a small number of studies have examined the epidemiology of systemic lupus erythematosus (SLE) on a nation-wide basis. These studies were…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology